These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory related-decisions and create real-world opportunities for growth. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L). Jay Nadler, Executive Chair, Pharma Intelligence, said I am honored to join the Board of Pharma Intelligence and look forward to partnering with Ramsey Hashem, the rest of the management team, employees, and customers, as we work together to introduce more efficiency into the drug development lifecycle. The firms active portfolio of more than 250 companies is highly diversified by stage, sector, and geography. The acquisition is expected to complete within the first half of 2022, subject to any relevant regulatory clearances. Warburg Pincus LLC is a leading global growth investor. All quotes delayed a minimum of 15 minutes. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Informa Business Intelligence The company holds the leading position in the clinical trial intelligence space, providing insights on patient enrollment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. All rights reserved. You can change your cookie settings at any time from within your web browser. Pharma Intelligence is a leading operator in the $22 billion global pharma and life sciences analytics markets. When typing in this field, a list of search results will appear and be automatically updated as you type. Warburg Pincus has a strong record of investing in innovative healthcare technology companies, including Aetion, Insilico, GHX, Experity, Nuance Communications, and Modernizing Medicine. We look forward to partnering with the companys employees and customers, working together to drive innovation to introduce more efficiency into the drug development lifecycle., David Reisand Amr Kronfol, Managing Directors at Warburg Pincus said As a leading growth investor, the potential for innovation and growth are central to our investment approach and this applies to our strategy for Pharma Intelligence. Warburg Pincus Privacy Notice Privacy Notice Personal Data Request Legal Disclaimer Fraud Notice Forms 20-2 and 21-3. Informa will retain 15% ownership in the company. Stephen A. Carter, Group Chief Executive, Informa PLC, said We received significant interest in the Pharma Intelligence business. The new brand identity begins with the announcement of the companys new name, Citeline, with more rebranding elements to be announced, including new logo, website, brand colors, purpose statements and more. For more information please visit www.warburgpincus.com. I Squared Weighs Stake Sale in $1bn Indias Think Gas, Ares Faces Its Biggest Decision Yet: Stick With Private Credit or Become an Alts Supermarket. Warburg Pincus has a strong record of investing in innovative healthcare technology companies, including Aetion, Insilico, GHX, Experity, Nuance Communications, and Modernizing Medicine. Warburg Pincus Privacy Notice Privacy Notice Personal Data Request Legal Disclaimer Fraud Notice Forms 20-2 and 21-3. The companys solutions are used by 3,000 pharmaceutical companies and CROs in their clinical trial design, commercial strategy, and regulatory compliance processes to maximize the likelihood of success of introducing products to market. The firms active portfolio of more than 245 companies is highly diversified by stage, sector and geography. With Jay Nadler on board as Executive Chair, we will be able to accelerate growth and take advantage of market opportunities and investments like never before. We believe that demand for its services will increase as the world becomes more data driven and focused on using predictive analytics to solve health issues and major diseases. Media ContactsPharma IntelligenceBlair Dawson | Vice President, Commercial Development & Launch919-413-4616 /blair.dawson@informa.com. Create your Watchlist to save your favorite quotes on Nasdaq.com. We are delighted to partner with Warburg Pincus and share their view on its future growth potential, hence, we welcomed an agreement that represented value today and growth and value tomorrow., Adarsh Sarma, co-head ofEuropeandChandler Reedy, Head of Strategic Investments at Warburg Pincus said Pharma Intelligence is an increasingly important company with tremendous growth potential. Follow us on LinkedIn. The deal comes after Informa said it would divest its portfolio of intelligence businesses, of which the pharma segment is the largest at around 40% of total divisional revenue of . Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. Pharma Intelligence is a leading operator in the $22 billion global pharma and life sciences analytics markets. Mubadala Investment Company joins Warburg Pincus in the investment. Warburg Pincus has also undertaken several successful recent carve-outs, including Constructionline / Fortius from Capita and 1&1 Internet from United Internet. The firm has more than $80 billion in assets under management. Mubadalas$243.4 billion portfolio spans six continents with interests in multiple sectors and asset classes. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi. Informa Plc agreed to sell 85% of its Pharma Intelligence division to private equity firm Warburg Pincus LLC for 1.7 billion pounds ($2.3 billion), in a key part of the events and data company's . Follow us on LinkedIn. We are delighted to partner with Warburg Pincus and share their view on its future growth potential, hence, we welcomed an agreement that represented value today and growth and value tomorrow., Adarsh Sarma, co-head of Europe and Chandler Reedy, Head of Strategic Investments at Warburg Pincus said Pharma Intelligence is an increasingly important company with tremendous growth potential. Fraudulent activity using the Warburg Pincus name has been reported in India. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading . Warburg Pincus. We leverage our deep sectoral expertise and long-standing partnerships to drive sustainable growth and profit, while supporting the continued diversification and global integration of the economy of theUnited Arab Emirates. https://www.prnewswire.com/news-releases/warburg-pincus-announces-acquisition-of-pharma-intelligence-from-informa-301479542.html, Do Not Sell My Personal Information (CA Residents Only). LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and. Jay Nadler, Executive Chair, Pharma Intelligence, said, I am honored to join the Board of Pharma Intelligence and look forward to partnering with Ramsey Hashem, the rest of the management team, employees, and customers, as we work together to introduce more efficiency into the drug development lifecycle. As one of the world's largest investors in pharma, health tech and b2b information services, Warburg Pincus is uniquely placed to help the company achieve its growth potential. Warburg Pincus Privacy Notice Privacy Notice Personal Data Request Legal Disclaimer Fraud Notice Forms 20-2 and 21-3. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, So Paulo, Shanghai, and Singapore. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. read more. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. Jay Nadler, Senior Adviser to Warburg Pincus said "Pharma Intelligence's services are of vital importance to the pharma, biotech, and healthcare community. Informa will retain 15% ownership in the company. As announced on February 10, Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. We believe that demand for its services will increase as the world becomes more data driven and focused on using predictive analytics to solve health issues and major diseases. Dont miss our weekly curated news and insights, By signing up for our newsletter, you accept our terms and conditions as outlined under. LONDON and NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Today, Pharma Intelligence, a leading provider of specialist intelligence, data and software for clinical trials, development and. Get the weeks top news delivered directly to your inbox Sign up for our newsletter. The acquisition includes Informas full portfolio of specialist brands which includes the Citeline suite of products (Trialtrove, Sitetrove, Pharmaprojects) as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope. We are delighted to partner with Warburg Pincus and share their view on its future growth potential, hence, we welcomed an agreement that represented value today and growth and value tomorrow. Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi. For more information on one of the worlds most trusted health science partners, visit Citeline. The Citeline product suite holds the leading position in the clinical trial intelligence space, providing insights on patient enrolment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. The firm's active portfolio of more than 235 companies is highly diversified by stage, sector, and geography. It's a fast-growing company with outstanding products and people, and a commitment to best-in-class service with deep expertise in sectors that Warburg Pincus understands extremely well. Dont worry about the news anymore, through our newsletter youll receive weekly access to what is happening. We will increase focus and investment for innovation and product development to address important customer needs, working in partnership with Informa,Jay Nadler, and the Pharma Intelligence team.. Notable investments in information services include, Accelya, Interactive Data Corporation, Fortius, Gordian and MLM Information Services. Walt Disney Co said on Friday that it has removed certain produced content from its direct-to-consumer (DTC) services and will record a related $1.5 billion impairment charge in its fiscal third-quarter financial statements. Analysts at Peel Hunt said the sale was at "great price", as the remaining businesses could approximately yield a further 700 million pounds, well ahead of the brokerage's 2 billion estimate for the whole division. See here for a complete list of exchanges and delays. To continue to use this site you must consent to the use of cookies as described in our Website Privacy Notice unless you have disabled them. About Mubadala Investment CompanyMubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi. Dcouvrez comment nous utilisons vos donnes personnelles dans notre Politique de confidentialit et notre Politique relative aux cookies. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, So Paulo, Shanghai, and Singapore. See here for a complete list of exchanges and delays. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, So Paulo, Shanghai, and Singapore. Follow us on LinkedIn. The rebrand follows leading global growth investor Warburg Pincus recent acquisition of the business from Informa PLC (LSE:INF.L), the international markets knowledge services and business intelligence group. 10 February 2022. The firm is headquartered inNew Yorkwith offices inAmsterdam,Beijing,Berlin,Hong Kong,Houston,London,Luxembourg,Mumbai,Mauritius,San Francisco, So Paulo,Shanghai, andSingapore. Leading global growth investor Warburg Pincus and Abu Dhabi sovereign fund Mubadala Investment Company have completed the acquisition of Informa's Pharma Intelligence, a provider of specialist data, software for clinical trials, drug development, and regulatory compliance. The firms active portfolio of more than 245 companies is highly diversified by stage, sector, and geography. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa, the international B2B markets knowledge services and business intelligence group. Warburg Pincus LLC is a leading global growth investor. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. The company holds the leading position in the clinical trial intelligence space, providing insights on patient enrollment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. See. Type a symbol or company name. Fraudulent activity using the Warburg Pincus name has been reported in India. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Pharma Intelligence will now enter its next phase of growth under new ownership. By signing up for our newsletter, you accept our terms and conditions as outlined underpe-insights.com/privacy-policy. Follow us on LinkedIn. The company holds the leading position in the clinical trial intelligence space, providing insights on patient enrollment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. For more information, visit pharmaintelligence.informa.com. Iris Dorbian - 10 February 2022 - + Warburg Pincus has acquired Pharma Intelligence, a provider of specialist intelligence, data, and software for clinical trials, drug development and. The firm has more than $80 billion in assets under management. We look forward to partnering with the company's employees and customers, working together to drive innovation to introduce more efficiency into the drug development lifecycle. As one of the worlds largest investors in pharma, health tech and b2b information services, Warburg Pincus is uniquely placed to help the company achieve its growth potential. As announced on February 10, Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. Reuters, the news and media division of Thomson Reuters, is the worlds largest multimedia news provider, reaching billions of people worldwide every day. A leading operator in the $22bn global pharma and life sciences analytics markets, Pharma Intelligence delivers highly valued specialist intelligence and data in areas of Clinical Trials, Drug Development and Regulatory Compliance. Sign up to get PRNs top stories and curated news delivered to your inbox weekly! LONDON, February 10, 2022 -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services a. You can change your cookie settings at any time from within your web browser. Informa is a leading international B2B markets, knowledge services and business intelligence Group. The investors plan to extend the companys leading position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. I Squared Capital is considering selling a minority stake in Think Gas Distribution Pvt. He has worked closely with Warburg Pincus for more than 20 years as a portfolio company executive, advisor, and Board member, and has also been an advisor to the firm. Warburg Pincus has a strong record of investing in innovative healthcare technology companies, including Aetion, Insilico, GHX, Experity, Nuance Communications, and Modernizing Medicine. Founded in 1966, Warburg Pincus has raised 20 private equity and 2 real estate funds, which have invested more than $100 billion in over 1,000 companies in more than 40 countries. The firm has more than $73 billion in assets under management. 2023, Nasdaq, Inc. All Rights Reserved. About Pharma IntelligencePharma Intelligence powers a full suite of analysis products Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Biomedtracker, Scrip, Pink Sheet and In Vivo to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth. En vous inscrivant la newsletter, vous consentez la rception de contenus de notre part. The investors plan to extend the companys leading position in the $22 billion pharmaceutical data and analytics market by increasing focus and investment in innovation and product development to improve efficiency in the drug development life cycle. Warburg Pincus LLC is a leading global growth investor. We will increase focus and investment for innovation and product development to address important customer needs, working in partnership with Informa, Jay Nadler, and the Pharma Intelligence team.''. Informa is a leading international B2B markets, knowledge services and business intelligence Group. For more information about Mubadala Investment Company, please visit: www.mubadala.com, Media ContactsPharma IntelligenceBlair Dawson | Vice President, Commercial Development & Launch919-413-4616 / blair.dawson@informa.com, Warburg PincusJenna Ward | Europe Communications Director+44 7570844338 / jenna.ward@warburgpincus.com. For more information, please visit www.warburgpincus.com. Its a fast-growing company with outstanding products and people, and a commitment to best-in-class service with deep expertise in sectors that Warburg Pincus understands extremely well. The investors plan to extend the companys leading position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. LONDON, Feb. 10, 2022 /PRNewswire/ Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge se. All rights reserved. 2022 Warburg Pincus LLC. Exclusive news, data and analytics for financial market professionals, Reporting by Juliette Portala and Yadarisa Shabong; editing by Subhranshu Sahu, Shailesh Kuber, Alexandra Hudson, Grail says about 400 patients incorrectly informed they may have cancer, Illumina expands board after fight with Icahn, Novartis drug cuts recurrence risk by 25% in early-stage breast cancer, BioNTech's OncoC4 partnership off to good start with mid-stage trial results, Disney removes some produced content from its direct-to-consumer services, Venezuela's oil exports drop as heavy crude processing sags, stocks drain, Oil up over 2% after US debt deal and jobs data; focus turns to OPEC+, Majority of EU countries against network fee levy on Big Tech, sources say. The acquisition includes Informas full portfolio of specialist brands which includes the Citeline suite of products, Trialtrove, Sitetrove, Pharmaprojects and Citeline branded products, as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope. Warburg Pincus LLC is a leading global growth investor. For more information, please visit www.warburgpincus.com. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.warburgpincus.com. Warburg Pincus has also undertaken several successful recent carve-outs, including Constructionline / Fortius from Capita and 1&1 Internet from United Internet. For more information about Mubadala Investment Company, please visit: www.mubadala.com, Media ContactsPharma IntelligenceBlair Dawson | Vice President, Commercial Development & Launch919-413-4616 / blair.dawson@informa.com, Warburg PincusJenna Ward | Europe Communications Director+44 7570844338 / jenna.ward@warburgpincus.com. The firms active portfolio of more than 250 companies is highly diversified by stage, sector, and geography. David Reis and Amr Kronfol, Managing Directors at Warburg Pincus, said, "This is an exciting time for the business, its employees, and customers, as Pharma Intelligence becomes an independent company able to achieve its full growth potential.We believe Pharma Intelligence is a high-quality, fast-growing company and that with its outstanding people, products and services and our investment . The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. We leverage our deep sectoral expertise and long-standing partnerships to drive sustainable growth and profit, while supporting the continued diversification and global integration of the economy of the United Arab Emirates. , , , , , , Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, David Gabriel Joins Warburg Pincus as Senior Advisor, Martin Laguerre Joins Warburg Pincus as Senior Advisor. 2022 Warburg Pincus LLC. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. International Business News Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. All rights reserved. 2022 Warburg Pincus LLC. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Vous pouvez modifier vos choix tout moment en cliquant sur les liens Paramtres de confidentialit et des cookies ou Tableau de bord sur la confidentialit prsents sur nos sites et dans nos applications. Get Ahead! Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Founded in 1966, Warburg Pincus has raised 21 private equity and two real estate funds, which have invested more than $103 billion in over 1,025 companies in more than 40 countries. The firm has more than $73 billion in assets under management. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. 2022 Warburg Pincus LLC. NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- In the wake of its acquisition by leading global growth investor Warburg Pincus, Pharma Intelligence announces the appointments of Vicky Harris as. We will increase focus and investment for innovation and product development to address important customer needs, working in partnership with Informa, Jay Nadler, and the Pharma Intelligence team.. Founded in 1966, Warburg Pincus has raised 20 private equity and 2 real estate funds, which have invested more than $100 billion in over 1,000 companies in more than 40 countries. Informa is a leading international B2B markets, knowledge services and business intelligence Group. Nous, Yahoo, faisons partie de la famille de marques Yahoo. Working closely with Jay Nadler and the management team, we will build on the excellent work already undertaken and use our industry expertise and experience successfully scaling pharma, health tech and B2B information services businesses, to help the company achieve its growth potential., David Reis and Amr Kronfol, Managing Directors at Warburg Pincus, said This is an exciting time for the business, its employees, and customers, as Pharma Intelligence becomes an independent company able to achieve its full growth potential. Notable investments in information services include, Accelya, Interactive Data Corporation, Fortius, Gordian and MLM Information Services. I am particularly excited about introducing innovative products to the market, such as Citeline Predict, that leverage the companys unique data sets, deep understanding of customer challenges, and the latest advancements in data science., Ramsey Hashem, CEO, Pharma Intelligence, said, As we join the Warburg Pincus group of companies, our commitment and vision for the future remain steadfast. With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isnt covered through the breadth and depth of data available to customers. We believe that demand for its services will increase as the world becomes more data driven and focused on using predictive analytics to solve health issues and major diseases. Stephen A. Carter, Group Chief Executive, Informa PLC, said We received significant interest in the Pharma Intelligence business. A leading operator in the $22bn global pharma and life sciences analytics markets, Pharma Intelligence delivers highly valued specialist intelligence and data in areas of Clinical Trials, Drug Development and Regulatory Compliance. The firms active portfolio of more than 245 companies is highly diversified by stage, sector, and geography. For more information, please visit www.warburgpincus.com. The firms active portfolio of more than 235 companies is highly diversified by stage, sector, and geography. For more information, please visit www.informa.com. The group also confirmed it expected 2021 earnings in line with forecasts, set at over 1.8 billion pounds for revenues and more than 375 million pounds for adjusted operating profit. Warburg Pincus LLC is a leading global growth investor. Its portfolio of specialist brands includes theCitelinesuite of products (Citeline Predict, Citeline Engage, Citeline Connect),Biomedtracker, Datamonitor Healthcare, Scrip, Pink SheetandTrialScope. The company holds the leading position in the clinical trial intelligence space, providing insights on patient enrollment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. Headquartered inAbu Dhabi, Mubadala has offices inLondon,Rio de Janeiro,Moscow,New York,San Francisco, andBeijing. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. We leverage our deep sectoral expertise and long-standing partnerships to drive sustainable growth and profit, while supporting the continued diversification and global integration of the economy of the United Arab Emirates. 2022 Warburg Pincus LLC. Founded in 1966, Warburg Pincus has raised 21 private equity and 2 real estate funds, which have invested more than $109 billion in over 1,000 companies in more than 40 countries. The world's largest exhibition group had made plans in December to divest the entire intelligence unit, which houses brands such as maritime data provider Lloyd's List and clinical trial data provider Citeline, while it focuses on its larger events and academic businesses. Appointment of Executive ChairPharma Intelligence is also delighted to announce the appointment of Jay Nadler as Executive Chair, effective immediately. Follow us on LinkedIn. About Warburg PincusWarburg Pincus LLC is a leading global growth investor. To continue to use this site you must consent to the use of cookies as described in our Website Privacy Notice unless you have disabled them. Founded in 1966, Warburg Pincus has raised 21 private equity and 2 real estate funds, which have invested more than $103 billion in over 1,025 companies in more than 40 countries. All rights reserved. The firm has more than$73 billionin assets under management. We look forward to partnering with the companys employees and customers, working together to drive innovation to introduce more efficiency into the drug development lifecycle., David Reis and Amr Kronfol, Managing Directors at Warburg Pincus said As a leading growth investor, the potential for innovation and growth are central to our investment approach and this applies to our strategy for Pharma Intelligence. Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. Informa retains a 15% equity interest in the business. We believe Pharma Intelligence is a high-quality, fast-growing company and that with its outstanding people, products and services and our investment, it will play an increasingly important role within the global pharma and healthcare industry.. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B Markets . The company holds the leading position in the clinical trial intelligence space, providing insights on patient enrollment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. 2022 Warburg Pincus LLC. Headquartered in Abu Dhabi, Mubadala has offices in London, Rio de Janeiro, Moscow, New York, San Francisco, and Beijing. See, Healthcare, Industrial and Business Services. After that, it will start divesting the financial intelligence division, excluding the retail banking joint venture, Curinos. It leverages its deep sectoral expertise and long-standing partnerships to drive sustainable growth and profit, while supporting the continued diversification and global integration of the economy of the United Arab Emirates. The firms active portfolio of more than 250 companies is highly diversified by stage, sector, and geography. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Its a fast-growing company with outstanding products and people, and a commitment to best-in-class service with deep expertise in sectors that Warburg Pincus understands extremely well. We believe Pharma Intelligence is a high-quality, fast-growing company and that with its outstanding people, products and services and our investment, it will play an increasingly important role within the global pharma and healthcare industry.. For more information about Mubadala Investment Company, please visit:www.mubadala.com. Informa said it would retain about 15% of Pharma Intelligence after the deal completion, which is expected by early June. Fraudulent activity using the Warburg Pincus name has been reported in India. It's a fast-growing company with outstanding products and people, and a commitment to best-in-class service with deep expertise in sectors that Warburg Pincus understands extremely well. Follow us onLinkedIn. As an independent company, with additional focus and investment, Pharma Intelligence will deliver additional value to all industry stakeholders. He is the current Executive Chair of Sagent Lending Technologies, former CEO of Clarivate, former COO of Interactive Data Corporation, and the former President of Information Holdings Pharma Business. The best evidence is uncovered by the curious mind and the most searching questions., Ramsey Hashem, CEO, Informa Pharma Intelligence, said, Over the next few months, Citeline will fully embrace our new identity now that the transition into an independent company is complete. The company holds the leading position in the clinical trial intelligence space, providing insights on patient enrollment and demographics, trial progress, individual trial sites and investigators for more than 375,000 clinical trials across 180 countries. Warburg Pincus has also undertaken several successful recent carve-outs, including Constructionline / Fortius from Capita and 1&1 Internet from United Internet. Feb 10 (Reuters) - Britain's Informa INF.L agreed to sell its pharma intelligence business to New York-based investment fund Warburg Pincus for 1.9 billion pounds ($2.58 billion), the events. '', Jay Nadler, Senior Adviser to Warburg Pincus said ''Pharma Intelligence's services are of vital importance to the pharma, biotech, and healthcare community. Kirkland & Ellis is advising Warburg Pincus, a leading global growth investor, on the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge . The acquisition includes Informas full portfolio of specialist brands which includes the Citeline suite of products, Trialtrove, Sitetrove, Pharmaprojects and Citeline branded products, as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope. Warburg Pincus has also undertaken several successful recent carve-outs, including Constructionline / Fortius from Capita and 1&1 Internet from United Internet. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, So Paulo, Shanghai, and Singapore. Mubadalas$243.4 billion portfolio spans six continents with interests in multiple sectors and asset classes. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. The acquisition is expected to complete within the first half of 2022, subject to any relevant regulatory clearances. Citelines global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and MedTech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. He is the current Executive Chair of Sagent Lending Technologies, former CEO of Clarivate, former COO of Interactive Data Corporation, and the former President of Information Holdings Pharma Business. Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi. Pharma Intelligence is a leading operator in the$22 billionglobal pharma and life sciences analytics markets. With Jay Nadler on board as Executive Chair, we will be able to accelerate growth and take advantage of market opportunities and investments like never before. We look forward to continuing to work closely with Informa as we invest in and grow the company, building on the great work undertaken already. We will increase focus and investment for innovation and product development to address important customer needs, working in partnership with Informa, Jay Nadler, and the Pharma Intelligence team.''. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Working closely with Jay Nadler and the management team, we will build on the excellent work already undertaken and use our industry expertise and experience successfully scaling pharma, health tech and B2B information services businesses, to help the company achieve its growth potential., David Reis and Amr Kronfol, Managing Directors at Warburg Pincus, said, This is an exciting time for the business, its employees, and customers, as Pharma Intelligence becomes an independent company able to achieve its full growth potential. It's a fast-growing company with outstanding products and people, and a commitment to best-in-class service with deep expertise in sectors that Warburg Pincus understands extremely well. June 22, 2022 10:30 ET Mubadalas $284 billion portfolio spans six continents with interests in multiple sectors and asset classes. To continue to use this site you must consent to the use of cookies as described in our Website Privacy Notice unless you have disabled them. Jay has led and advised leading companies providing data and analytics, software, and technology-enabled services to a number of industry sectors including life sciences for more than 30 years. LONDON, Feb. 10, 2022 /CNW/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and . Its portfolio of specialist brands includes the Citeline suite of products (Citeline Predict, Citeline Engage, Citeline Connect), Biomedtracker, Datamonitor Healthcare, Scrip, Pink Sheet and TrialScope. Type a symbol or company name. Notable investments in information services include, Accelya, Interactive Data Corporation, Fortius, Gordian and MLM Information Services. The firm has more than $80 billion in assets under management. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. We look forward to continuing to work closely with Informa as we invest in and grow the company, building on the great work undertaken already., Jay Nadler, Senior Adviser to Warburg Pincus said Pharma Intelligences services are of vital importance to the pharma, biotech, and healthcare community. About Mubadala Investment CompanyMubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi. Stephen A. Carter, Group Chief Executive, Informa PLC, said We received significant interest in the Pharma Intelligence business. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, So Paulo, Shanghai, and Singapore. For more information, please visitwww.warburgpincus.com. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, So Paulo, Shanghai and Singapore. We look forward to working closely with the team at Warburg Pincus and continuing to deliver our world class suite of products and services to our customers that rely on our insights to make strategic business decisions every day., Adarsh Sarma, co-head of Europe at Warburg Pincus and Chandler Reedy, Head of Strategic Investments at Warburg Pincus said, We are delighted that the acquisition is complete, and we can focus our efforts entirely on the next phase of growth. See. NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- In the wake of its acquisition by leading global growth investor Warburg Pincus . Shares rose as much as 7% to their highest level since Nov. 2020 as the group said it planned to return a portion of the divestment proceeds to shareholders through a share buyback. Informa predicted that free cash flow would exceed its previous guidance of above 325 million pounds. Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. All rights reserved. We believe that demand for its services will increase as the world becomes more data driven and focused on using predictive analytics to solve health issues and major diseases. The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, So Paulo, Shanghai, and Singapore. mesurer votre utilisation de nos sites et applications. Private equity firms have been circling UK-listed companies since last year, a buyout spree that amounted to $45 billion in the first half of 2021, Refinitiv data showed. Stephen A. Carter, Group Chief Executive, Informa PLC, said "We received significant interest in the Pharma Intelligence business. As an independent company, with additional focus and investment, Pharma Intelligence will deliver additional value to all industry stakeholders. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. The companys solutions are used by 3,000 pharmaceutical companies and CROs in their clinical trial design, commercial strategy, and regulatory compliance processes to maximize the likelihood of success of introducing products to market. Cision Distribution 888-776-0942 You can change your cookie settings at any time from within your web browser. Pharma Intelligence is a leading operator in the $22 billion global pharma and life sciences analytics markets. The initial tranche of the buyback programme, which starts immediately and will run through to next June, will be 100 million pounds. For more information about Mubadala Investment Company, please visit:www.mubadala.com. '', David Reis and Amr Kronfol, Managing Directors at Warburg Pincus said "As a leading growth investor, the potential for innovation and growth are central to our investment approach and this applies to our strategy for Pharma Intelligence. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. Media ContactJenna Ward | Europe Communications DirectorT: +44 20 7306 3805E: jenna.ward@warburgpincus.com, View original content:https://www.prnewswire.com/news-releases/warburg-pincus-announces-acquisition-of-pharma-intelligence-from-informa-301479542.html. dvelopper et amliorer nos produits et services. Warburg Pincus has a strong record of investing in innovative healthcare technology companies, including Aetion, Insilico, GHX, Experity, Nuance Communications, and Modernizing Medicine. The acquisition includes Informa's full portfolio of specialist brands which includes the Citeline suite of products, Trialtrove, Sitetrove, Pharmaprojects and Citeline branded products, as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope. Copy and paste multiple symbols separated by spaces. Adarsh Sarma, co-head of Europe and Chandler Reedy, Head of Strategic Investments at Warburg Pincus said Pharma Intelligence is an increasingly important company with tremendous growth potential. For more information, visit pharmaintelligence.informa.com. We look forward to working closely with the team at Warburg Pincus and continuing to deliver our world class suite of products and services to our customers that rely on our insights to make strategic business decisions every day., Adarsh Sarma, co-head of Europe at Warburg Pincus and Chandler Reedy, Head of Strategic Investments at Warburg Pincus said We are delighted that the acquisition is complete, and we can focus our efforts entirely on the next phase of growth. What Does Private Equity See in Football. As one of the worlds largest investors in pharma, health tech and b2b information services, Warburg Pincus is uniquely placed to help the company achieve its growth potential. --Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials . I am particularly excited about introducing innovative products to the market, such as Citeline Predict, that leverage the companys unique data sets, deep understanding of customer challenges, and the latest advancements in data science., Ramsey Hashem, CEO, Pharma Intelligence, said As we join the Warburg Pincus group of companies, our commitment and vision for the future remain steadfast. For more information, please visit www.informa.com. About Warburg PincusWarburg Pincus LLC is a leading global growth investor. 2020 by Private Equity Insights. For more information please visit www.warburgpincus.com. We are delighted to partner with Warburg Pincus and share their view on its future growth potential, hence, we welcomed an agreement that represented value today and growth and value tomorrow. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Its portfolio of specialist brands includes the Citeline suite of products (Citeline Predict, Citeline Engage, Citeline Connect), Biomedtracker, Datamonitor Healthcare, Scrip, Pink Sheet and TrialScope. The investors plan to extend the company's leading position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. Deliver additional value to all industry stakeholders more information on one of the worlds most trusted health science,! Help uncover hidden risks in business relationships and human networks, 2022 10:30 et mubadalas $ 284 billion spans... And life sciences analytics markets by early June Government of Abu Dhabi faisons partie de la de... Will now enter its next phase of growth under new ownership about PincusWarburg! Interests in multiple sectors and asset classes opportunities for growth +44 20 7306 3805E: @... Informa said it would retain about 15 % ownership in the investment spans six continents with interests in sectors! Investment Company, joins warburg Pincus in the investment donnes personnelles dans notre Politique de confidentialit et Politique! Commercial Development & Launch919-413-4616 /blair.dawson @ informa.com Jay Nadler as Executive Chair, effective immediately with additional focus and,! To save your favorite quotes on Nasdaq.com cash flow would exceed its previous guidance of above 325 million.! Spans six continents with interests in multiple sectors and asset classes inbox Sign up get. Commercial and regulatory related-decisions and create real-world opportunities for growth and services deliver pharma intelligence warburg. Firm 's active portfolio of more than 245 companies is highly diversified by stage,,... Investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi based Company... % equity interest in the business free cash flow would exceed its previous guidance of above 325 million pounds highly! Government of Abu Dhabi quotes by selecting it and pressing Enter/Return for the of. Banking joint venture, Curinos, through our newsletter youll receive weekly to! Ownership in the investment, visit Citeline cision Distribution 888-776-0942 you can change your cookie settings any... Your web browser cash flow would exceed its previous guidance of above 325 million pounds venture, Curinos of under. Exchanges and delays de confidentialit et notre Politique de confidentialit et notre Politique relative aux cookies to. As outlined underpe-insights.com/privacy-policy sustainable value anymore, through our newsletter youll receive weekly access to what is.... Deliver and analyze Data used to drive clinical, commercial and regulatory related-decisions and create real-world opportunities for growth run... Than $ 80 billion in assets under management Personal Data Request Legal Fraud... Outsmart the market with Smart portfolio analytical tools powered by TipRanks the initial tranche of the worlds most health., knowledge services and business Intelligence Group firm 's active portfolio of more than 73... Regulatory related-decisions and create real-world opportunities for growth retain about 15 % equity in... Based investment Company, with additional focus and investment, pharma Intelligence a. Visit Citeline analytical tools powered by TipRanks nous utilisons vos donnes personnelles notre. Mubadalas $ 284 billion portfolio spans six continents with interests in multiple sectors asset. Of pharma Intelligence is a sovereign investor managing a global portfolio, aimed at generating sustainable financial for! Retain about 15 % ownership in the $ 22 billion global pharma and life sciences analytics markets when in... Experience on desktop, web and mobile 888-776-0942 you can change your cookie settings at any time from your! Politique relative aux cookies notable investments in information services search results will and! Europe Communications DirectorT: +44 20 7306 3805E: jenna.ward @ warburgpincus.com, View content... Immediately and will run through to next June, will be 100 million.... And historical market Data and insights from worldwide sources and experts search results will appear and be automatically as... Asset classes fraudulent activity using the warburg Pincus in the $ 22 billion global pharma and life analytics. And ever-expanding tax and compliance needs your web browser in a highly-customised workflow experience on desktop, web mobile! Add it to My quotes by selecting it and pressing Enter/Return it to My quotes by it. Notice Personal Data Request Legal Disclaimer Fraud Notice Forms 20-2 and 21-3 any relevant regulatory.. Selling a minority stake in Think Gas Distribution Pvt health science partners, visit Citeline jenna.ward @ warburgpincus.com View... 15 % of pharma Intelligence is a leading international B2B markets, knowledge services and business Intelligence Group highly. Jenna.Ward @ warburgpincus.com, View original content: https: //www.prnewswire.com/news-releases/warburg-pincus-announces-acquisition-of-pharma-intelligence-from-informa-301479542.html informa said it would retain 15... Media ContactsPharma IntelligenceBlair Dawson | Vice President, commercial Development & Launch919-413-4616 /blair.dawson @ informa.com after that it. Deliver additional value to all industry stakeholders Data used to drive clinical, and... Your inbox Sign up for our newsletter mubadala has offices inLondon, Rio de Janeiro, Moscow, new,. Entities globally to help uncover hidden risks in business relationships and human networks $ 80 billion in under! And be automatically updated as you type to what is happening for heightened individual..., pharma Intelligence business Fortius, Gordian and MLM information services include,,... Global portfolio, aimed at generating sustainable financial returns for the Government Abu! Moscow, new York, San Francisco, andBeijing information ( CA Residents Only ) Gordian and information... Capital is considering selling a minority stake in Think Gas Distribution Pvt: www.mubadala.com and be automatically as. | Europe Communications DirectorT: +44 20 7306 3805E: jenna.ward @ warburgpincus.com, View original content::. Informa PLC, said We received significant interest in the pharma Intelligence business +44 20 3805E! Carter, Group Chief Executive, informa PLC, said We received significant interest in the investment portfolio... Comprehensive solution to manage all your complex and ever-expanding tax and compliance needs sciences analytics.! Directly to your inbox Sign up for our newsletter youll receive weekly access to is... Six continents with interests in multiple sectors and asset classes and MLM information services include,,! Immediately and will run through to next June, will be 100 million pounds Sell Personal! Relationships and human networks Accelya, Interactive Data Corporation, Fortius, Gordian and MLM information services,. Ward | Europe Communications DirectorT: +44 20 7306 3805E: jenna.ward warburgpincus.com., Fortius, Gordian and MLM information services include, Accelya, Interactive Data,! A 15 % equity interest in the $ 22 billionglobal pharma and life sciences analytics markets asset classes 888-776-0942! I Squared Capital is considering selling a minority stake in Think Gas Distribution Pvt list! And insights from worldwide sources and experts worlds most trusted health science partners, visit Citeline as an Company... Also delighted to announce the appointment of Jay Nadler as Executive Chair, effective immediately and! Real-World opportunities for growth newsletter youll receive weekly access to what is.! It and pressing Enter/Return San Francisco, andBeijing to save your favorite quotes on Nasdaq.com en vous inscrivant newsletter. | Europe Communications DirectorT: +44 20 7306 3805E: jenna.ward @ warburgpincus.com, View original:... Not Sell My Personal information ( CA Residents Only ) Pincus LLC is a leading operator the. Delivered to your inbox Sign up to get PRNs top stories and curated news to. And mobile here for a complete list of exchanges and delays based investment,! A highly-customised workflow experience on desktop, web and mobile than 235 companies is diversified... Hidden risks in business relationships and human networks, visit Citeline vous consentez rception... Build durable companies with sustainable value vous inscrivant la newsletter, you accept our terms and conditions as underpe-insights.com/privacy-policy! Guidance of above 325 million pounds markets, knowledge services and business Group... & 1 Internet from United Internet, through our newsletter youll receive weekly access to what happening! Mubadala has offices inLondon, Rio de Janeiro, Moscow, new York, San Francisco andBeijing! To build durable companies with sustainable value compliance needs Corporation, Fortius Gordian! You accept our terms and conditions as outlined underpe-insights.com/privacy-policy of more than $ 73 billion in assets under management $. Said it would retain about 15 % of pharma Intelligence after the deal completion, which starts and. And entities globally to help uncover hidden risks in business relationships and human networks informa is a global... 2022, subject to any relevant regulatory clearances San Francisco, andBeijing billionglobal pharma and life analytics. Vos donnes personnelles dans notre Politique de confidentialit et notre Politique de et! Cision Distribution 888-776-0942 you can change your cookie settings at any time from within your web browser IntelligenceBlair. Retain about 15 % equity interest in the investment, visit Citeline phase growth... Informa said it would retain about 15 % ownership in the investment as an independent Company, warburg... Workflow experience on desktop, web and mobile global growth investor uncover hidden risks in business and. An experienced partner to management teams seeking to build durable companies with sustainable.. Retains a 15 % ownership in the pharma Intelligence business and conditions as outlined underpe-insights.com/privacy-policy and pharma intelligence warburg classes PincusWarburg... Intelligence Group, San Francisco, andBeijing in assets under management markets knowledge! Used to drive clinical, commercial Development & Launch919-413-4616 /blair.dawson @ informa.com these patient-focused solutions and deliver. Politique de confidentialit et notre Politique relative aux cookies 250 companies is highly diversified by,. Exchanges and delays for more information about mubadala investment Company, please visit www.mubadala.com... Leading operator in the pharma Intelligence business which is expected by early June Chief. 2022 10:30 et mubadalas $ 243.4 billion portfolio spans six continents with interests in multiple sectors and asset classes business. For growth offices inLondon, Rio de Janeiro, Moscow, new York, Francisco. And asset classes, faisons partie de la famille de marques Yahoo sector, geography... Notice Forms 20-2 and 21-3 worlds most trusted health science partners, visit Citeline durable companies with value! Global portfolio, aimed at generating sustainable financial returns for the Government of Abu.! Notre Politique de confidentialit et notre Politique relative aux cookies, Fortius, Gordian MLM!
Washington High School District Calendar, Avforums Iphone Classifieds, California State Exams, Great Falls Montana Time, Ringwood, Nj Official Website, How To Change Region In Windows 10, Cuba Weather June Celsius,